Heparin and COVID-19: Case Studies Suggest Small Risk of Hematoma
Researchers sought to determine whether there was a risk of developing IPH in patients with COVID-19 treated with heparin.
Jonathan Goodman, MPhil
Jonathan was the editor of Cancer Therapy Advisor from 2016 to 2018. His work has appeared in Aeon Magazine, The Week, and The Guardian, among other publications.
